|
|
|
201-500 employees
View all
|
|
biotechnology
|
|
210 E Grand Ave,South San Francisco,California,US
|
|
Allogene Therapeutics is a clinical-stage biotechnology company pioneering the development of allogeneic chimeric antigen receptor T cell (AlloCAR TTM) therapies for cancer. The goal of our allogeneic cell therapy platform is simple: take the same biological processes that allow the first generation autologous CAR T (Auto CAR TTM) therapies to deliver breakthrough clinical benefits but eliminate the need to create a personalized therapy for each patient. Instead, we start with T cells from healthy donors, which is intended to allow for creation of inventory for “off-the-shelf” use in patients faster, more reliably, and at greater scale.For additional information on our guidelines, please visit www.allogene.com/news-center#community-guidelines
|
Allogene Therapeutics Email Formats | Example Email Formats | Percentage |
---|---|---|
{first}.{last} | [email protected] |
100%
|
The widely used Allogene Therapeutics email format is {first}.{last} (e.g. [email protected]) with 100% adoption across the company.
To contact Allogene Therapeutics customer service number in your country click here to find.
Find accurate personal emails, work emails and phone numbers for employees
Accelerate prospecting with instant access to 300M professionals from 30M companies with the right contact details.